EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 52022M10809

Prior notification of a concentration (Case M.10809 – CD&R / TPG / COVETRUS) Candidate case for simplified procedure (Text with EEA relevance) 2022/C 262/09

PUB/2022/766

OJ C 262, 7.7.2022, p. 13–14 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

7.7.2022   

EN

Official Journal of the European Union

C 262/13


Prior notification of a concentration

(Case M.10809 – CD&R / TPG / COVETRUS)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 262/09)

1.   

On 28 June 2022, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

Clayton, Dubilier & Rice Fund XI, L.P. and three other limited partnerships under common control (‘CD&R’, United States),

TPG Partners VIII, L.P. (‘TPG Partners VIII’), and TPG Healthcare Partners, L.P. (‘TPG Healthcare’) (‘TPG’, United States),

Covetrus, Inc. (‘Covetrus’, United States) (‘the Target’).

CD&R and TPG will acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Covetrus.

The concentration is accomplished by way of purchase of shares.

2.   

The business activities of the undertakings concerned are the following:

CD&R is a private equity investment firm which has investments in various sectors of the economy,

TPG is a private equity fund that invests in a variety of companies through acquisitions and corporate restructuring.

Covetrus is a publicly listed company active globally as a provider of animal-health technology and services to companies supporting the companion, equine and large-animal veterinary markets, specifically veterinarians and animal-health practitioners.

3.   

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.   

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

Case M.10809 – CD&R / TPG / COVETRUS

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË


(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.


Top